.avif)
.avif)
We research vaccines with decades of experience and internationally recognized, scientifically high-quality expertise. Our comprehensive network of clinics provides first-class conditions for this. Our special expertise includes extensive clinical vaccine studies covering all phases of the research cycle (1-4) and efficacy and safety studies of vaccines in general use. We have strong special expertise in observational RWE studies and pragmatic field studies, as well as in the utilization of Finland's comprehensive health data registers and data resources.
.svg)
Decades of vaccine research experience
170+ successful studies completed
Studies across all age groups, infants to seniors
Trusted member of the Finnish Pharmaceutical Industry Association
Nationwide clinic network under a single agreement
Seamless collaboration with healthcare providers
Strong track record from large-scale post-marketing studies
Excellent client satisfaction (NPS +70)
9.1/10 target achievement rate
Stable and reliable Finnish operating environment
97% volunteer satisfaction
Low dropout rate: 0.7%
Thousands of new volunteers recruited each year
Ilona Schmidt
Head of Key Accounts
ilona.schmidt@fvr.fi
Arto Palmu
Research and Medical Director
arto.palmu@fvr.fi
FVR conducts Phase 1–4 clinical trials of vaccines and medicines for people of all ages. At any given time, dozens of studies may be underway, involving thousands of volunteers each year. Participants are typically assigned either the investigational product or a comparator, which may be a placebo or an active control (such as a licensed vaccine). Most trials are blinded, meaning neither the participant nor the investigator knows which product was given during the study. Once the trial is completed, the blinding is lifted, and both are informed of the treatment received.
Vaccine safety and vaccine-related adverse events are usually the most important issues to be investigated in a study. Information on adverse events occurring during the study is collected in accordance with legislation and the study-specific research protocol.
Subjects participating in vaccine trials are instructed to report adverse events to the FVR research staff in accordance with study-specific instructions.
Often, potential adverse events are reported using regularly completed electronic diaries.
Information is also collected through regular study office visits and remote contacts.
Study participants can always contact their own vaccine trial clinic if they have any questions about the study or suspect unexpected adverse events.
The majority of studies are blinded, meaning that the subject and the investigator do not know during the implementation phase of the study which product the subject has received.
Unblinding during the study is possible, but information about the vaccine received in a vaccine trial (e.g. active study product or placebo) rarely affects the patient's treatment.
If, as a healthcare professional, you suspect that your patient has an adverse event related to the study vaccine, we recommend that you instruct the patient to report the matter to their own vaccine research clinic
In most cases, all sudden hospitalisations should also be reported to the investigator
FVR's vaccine research clinics answer questions from volunteers and healthcare professionals regarding studies and investigational products during weekdays during office hours
In urgent cases outside the vaccine research clinic’s opening hours, healthcare professionals can contact the central advisory service at +358 40 182 6641. This service is intended exclusively for healthcare professionals.
Tens of thousands of volunteers, both children and adults, have participated in vaccine research in Finland over the decades. Many public health nurses and doctors have shared information with their patients about ongoing vaccine studies. The contributions of both healthcare professionals and volunteer participants are essential to the success of these studies. A big thank you for your support—our cooperation has a significant impact on people’s wellbeing.
Children participating in vaccine studies also receive the vaccines included in the national vaccination program, often at the vaccine research clinic. Sometimes the study vaccine schedule differs from that of the Finnish vaccination programme.
Vaccines administered during vaccine studies are recorded at the vaccine research clinics in FVR’s patient information system, from which the data is transferred to the Patient Data Repository (Kanta) and the national vaccination register
We also record our participants’ vaccination data in their child health clinic card (neuvolakortti) or personal Health Card
The records include: the study name, the study vaccine (often blinded during the conduct of the study), any other routine vaccines given as part of the study, and the child’s age at the time of vaccination
Research is ongoing to ensure that new, tested vaccines become available and that the vaccination program can continue to develop. For this reason, we are always seeking new volunteers for our studies.
Our team mebers are happy to give presentations to public health nurses at child health clinics and other partners about ongoing studies, vaccine research in general, and the diseases preventable through vaccination.
If you would like to book an information session on vaccine research at your workplace, please contact your local vaccine research clinic.
FVR - Finnish Vaccine Research
Peltokatu 26, 33100 Tampere
Business ID 3256659-4
info@fvr.fi
Invoicing instructions
Data protection I About cookies I Self-monitoring plan
Osana-tuki: help@fvr.fi
Copyright 2025 FVR - Finnish Vaccine Research
